FDA Inspection 1028446 — Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
The FDA completed an inspection of Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) on September 20, 2017 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 20, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)